Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269245/
https://www.ncbi.nlm.nih.gov/pubmed/32492047
http://dx.doi.org/10.1371/journal.pone.0234365
_version_ 1783541740813156352
collection PubMed
description
format Online
Article
Text
id pubmed-7269245
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72692452020-06-10 Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells PLoS One Retraction Public Library of Science 2020-06-03 /pmc/articles/PMC7269245/ /pubmed/32492047 http://dx.doi.org/10.1371/journal.pone.0234365 Text en © 2020 The PLOS ONE Editors http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Retraction
Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title_full Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title_fullStr Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title_full_unstemmed Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title_short Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
title_sort retraction: dma, a bisbenzimidazole, offers radioprotection by promoting nfκb transactivation through nik/ikk in human glioma cells
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269245/
https://www.ncbi.nlm.nih.gov/pubmed/32492047
http://dx.doi.org/10.1371/journal.pone.0234365
work_keys_str_mv AT retractiondmaabisbenzimidazoleoffersradioprotectionbypromotingnfkbtransactivationthroughnikikkinhumangliomacells

Ejemplares similares